share_log

AbbVie | 144: Notice of proposed sale of securities pursuant to Rule 144

SEC announcement ·  Mar 19 05:07
Summary by Futu AI
AbbVie Inc. officer Stewart Jeffrey Ryan is set to sell 58,949 common shares of the company on March 18, 2024, with an aggregate market value of approximately $10,539,878. The shares to be sold were acquired through stock option exercises and performance shares, both as compensation from the issuer. On March 18, 2024, Ryan acquired 26,110 shares via stock option exercise, and on February 28, 2024, he acquired 32,839 shares as performance shares. There is no reportable history of securities sold in the past three months prior to this notice.
AbbVie Inc. officer Stewart Jeffrey Ryan is set to sell 58,949 common shares of the company on March 18, 2024, with an aggregate market value of approximately $10,539,878. The shares to be sold were acquired through stock option exercises and performance shares, both as compensation from the issuer. On March 18, 2024, Ryan acquired 26,110 shares via stock option exercise, and on February 28, 2024, he acquired 32,839 shares as performance shares. There is no reportable history of securities sold in the past three months prior to this notice.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.